Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes www.impactjournals.com/oncotarget/ Oncotarget, December, Vol.3, No 12 PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes 1 1 1 1 Filip Janku , Jennifer J. Wheler , Aung Naing , Vanda M. Stepanek , Gerald S. 1 1 1 1 Falchook , Siqing Fu , Ignacio Garrido-Laguna , Apostolia M. Tsimberidou , 1 1 2 3 Sarina A. Piha-Paul , Stacy L. Moulder , J. Jack Lee , Rajyalakshmi Luthra , David 1 4 S. Hong , Razelle Kurzrock Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Moores Cancer Center, The University of California San Diego, La Jolla, California, USA Correspondence to: Filip Janku, email: [email protected] Keywords: PIK3CA mutation, phenotypic taxonomy, clinical outcome Received: October 19, 2012, Accepted: November 30, 2012, Published: November 30, 2012 Copyright: © Janku et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncotarget Unpaywall

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes

Download PDF
10 pages

Loading next page...
 
/lp/unpaywall/pik3ca-mutations-in-advanced-cancers-characteristics-and-outcomes-2L6Htk1IOS

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
1949-2553
DOI
10.18632/oncotarget.716
Publisher site
See Article on Publisher Site

Abstract

www.impactjournals.com/oncotarget/ Oncotarget, December, Vol.3, No 12 PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes 1 1 1 1 Filip Janku , Jennifer J. Wheler , Aung Naing , Vanda M. Stepanek , Gerald S. 1 1 1 1 Falchook , Siqing Fu , Ignacio Garrido-Laguna , Apostolia M. Tsimberidou , 1 1 2 3 Sarina A. Piha-Paul , Stacy L. Moulder , J. Jack Lee , Rajyalakshmi Luthra , David 1 4 S. Hong , Razelle Kurzrock Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Moores Cancer Center, The University of California San Diego, La Jolla, California, USA Correspondence to: Filip Janku, email: [email protected] Keywords: PIK3CA mutation, phenotypic taxonomy, clinical outcome Received: October 19, 2012, Accepted: November 30, 2012, Published: November 30, 2012 Copyright: © Janku et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and

Journal

Oncotarget – Unpaywall

Published: Nov 30, 2012

There are no references for this article.